Significant reductions were seen in dementia risk for rivaroxaban, apixaban, and dabigatran versus warfarin in network meta-analysis
Your search for rivaroxaban returned 157 results
During extended treatment, bleeding risk was similar for apixaban and rivaroxaban.
Enrollees in the Medicare prescription drug program paid a total of $3.4 billion in out-of-pocket costs in 2022 for the 10 initial drugs chosen for price negotiations.
Andexxa was granted accelerated approval by the FDA in May 2018.
Risk up with amiodarone vs flecainide or sotalol among seniors with atrial fibrillation receiving apixaban or rivaroxaban.
Rivaroxaban 2.5mg, 10mg, 15mg, 20mg; tabs.
Apixaban dominated enoxaparin and edoxaban; rivaroxaban was slightly more effective than apixaban
Risk for recurrent venous thromboembolism reduced for patients with isolated distal DVT receiving six additional weeks of rivaroxaban
No substantial differences seen for other outcomes or for other direct oral anticoagulant comparisons
Apixaban and rivaroxaban are both factor Xa inhibitors.